The agent presented herein is an effective and safe sugar-derivative, for treatment of common colds induced by human rhinoviruses. It targets the life-cycle of the virus without major side effects for the patient, and could be applied in a nasal spray as a single compound medicament or in combination with already existing, conventional decongestant formulations of sprays against common cold.
Innovations offered:
Currently:
Preferred Cooperation:
□ Commercial Agreement with technical assistance
□ Technical Cooperation Agreement
□ Financial Investment Agreement
□ Joint Venture
R Licensing Agreement
□ Manufacturing Agreement
□ Research Collaboration Agreement
□ Services Agreement
Type of Partner sought:
Copyright © 2018 CHINA INTERNATIONAL TECHNOLOGY TRANSFER CENTER